Antimuscarinic Agents
Links shared publicly online about this topic
Medical News: Triple Therapy Reduces COPD Exacerbations - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “For moderate-to-severe chronic obstructive pulmonary disease (COPD), a triple regimen of a long-acting β-agonist (LABA), an inhaled corticosteroid, and an antimuscarinic agent substantially cuts” View full resource at medpagetoday.com
Most Recently Shared on October 8, 2009 at 7:21 pm By:
Triple Therapy Reduces COPD Exacerbations (CME/CE) http://ow.ly/15TGWI
Nursing News & Articles - MDLinx - Cognitive Science Muscarinic Antagonists Aged Urinary Bladder, Overactive
mdlinx.com — “Nursing News & Articles - MDLinx - Cognitive Science Muscarinic Antagonists Aged Urinary Bladder, Overactive” View full resource at mdlinx.com
Most Recently Shared on July 20, 2010 at 8:51 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder: Int... http://bit.ly/bVhmAg #Nursing
Urology Article | pharmacokinetics
mdlinx.com — “Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder” View full resource at mdlinx.com
Most Recently Shared on November 7, 2010 at 12:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimu... http://bit.ly/bQHKvp #urology
Triple Therapy Halves Exacerbations in Moderate-to-Severe COPD
newswise.com — “Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting -agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany.” View full resource at newswise.com
Most Recently Shared on October 8, 2009 at 5:36 am By:
Triple Therapy Halves Exacerbations in Moderate-to-Severe COPD http://bit.ly/1sqJ6C
Triple therapy halves exacerbations in moderate-to-severe COPD
eurekalert.org — “Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting beta-agonist, an inhaled corticosteroid and an anti-muscarinic agent, according to researchers in Germany.” View full resource at eurekalert.org
Most Recently Shared on October 8, 2009 at 4:30 am By:
AAAS Triple therapy halves exacerbations in moderate-to-severe COPD http://bit.ly/2j7ICg
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
